Cost effectiveness analysis of immunotherapy regimens currently approved in advanced or recurrent endometrial cancer: An analysis of the NRG-GY 018, RUBY, and DUO-E trials.
Saved in:
| Title: | Cost effectiveness analysis of immunotherapy regimens currently approved in advanced or recurrent endometrial cancer: An analysis of the NRG-GY 018, RUBY, and DUO-E trials. |
|---|---|
| Authors: | Francoeur AA; Department of Obstetrics and Gynecology, University of California, Irvine, Orange, CA, USA., Liang SY; Palo Alto Medical Foundation Research Institute, Sutter Health, Palo Alto, CA, USA., File B; Department of Obstetrics and Gynecology, University of California, Irvine, Orange, CA, USA., Choi E; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA., Brameld M; Palo Alto Medical Foundation Research Institute, Sutter Health, Palo Alto, CA, USA., Richardson MT; Department of Obstetrics and Gynecology, University of California Los Angeles, Los Angeles, CA, USA., Johnson CR; Palo Alto Medical Foundation Research Institute, Sutter Health, Palo Alto, CA, USA., Kapp DS; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA., Tewari KS; Department of Obstetrics and Gynecology, University of California, Irvine, Orange, CA, USA., Chan JK; Division of Gynecologic Oncology, California Pacific / Palo Alto / Sutter Health Research Institute, San Francisco, CA, USA. |
| Source: | Gynecologic oncology reports [Gynecol Oncol Rep] 2026 Feb 18; Vol. 64, pp. 102050. Date of Electronic Publication: 2026 Feb 18 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101652231 Publication Model: eCollection Cited Medium: Print ISSN: 2352-5789 (Print) Linking ISSN: 23525789 NLM ISO Abbreviation: Gynecol Oncol Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41767212 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost effectiveness analysis of immunotherapy regimens currently approved in advanced or recurrent endometrial cancer: An analysis of the NRG-GY 018, RUBY, and DUO-E trials. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Francoeur+AA%22">Francoeur AA</searchLink>; Department of Obstetrics and Gynecology, University of California, Irvine, Orange, CA, USA.<br /><searchLink fieldCode="AU" term="%22Liang+SY%22">Liang SY</searchLink>; Palo Alto Medical Foundation Research Institute, Sutter Health, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22File+B%22">File B</searchLink>; Department of Obstetrics and Gynecology, University of California, Irvine, Orange, CA, USA.<br /><searchLink fieldCode="AU" term="%22Choi+E%22">Choi E</searchLink>; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Brameld+M%22">Brameld M</searchLink>; Palo Alto Medical Foundation Research Institute, Sutter Health, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Richardson+MT%22">Richardson MT</searchLink>; Department of Obstetrics and Gynecology, University of California Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+CR%22">Johnson CR</searchLink>; Palo Alto Medical Foundation Research Institute, Sutter Health, Palo Alto, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kapp+DS%22">Kapp DS</searchLink>; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tewari+KS%22">Tewari KS</searchLink>; Department of Obstetrics and Gynecology, University of California, Irvine, Orange, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chan+JK%22">Chan JK</searchLink>; Division of Gynecologic Oncology, California Pacific / Palo Alto / Sutter Health Research Institute, San Francisco, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101652231%22">Gynecologic oncology reports</searchLink> [Gynecol Oncol Rep] 2026 Feb 18; Vol. 64, pp. 102050. <i>Date of Electronic Publication: </i>2026 Feb 18 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101652231 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2352-5789 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223525789%22">23525789 </searchLink><i>NLM ISO Abbreviation: </i>Gynecol Oncol Rep <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41767212 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.gore.2026.102050 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102050 Titles: – TitleFull: Cost effectiveness analysis of immunotherapy regimens currently approved in advanced or recurrent endometrial cancer: An analysis of the NRG-GY 018, RUBY, and DUO-E trials. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Francoeur AA – PersonEntity: Name: NameFull: Liang SY – PersonEntity: Name: NameFull: File B – PersonEntity: Name: NameFull: Choi E – PersonEntity: Name: NameFull: Brameld M – PersonEntity: Name: NameFull: Richardson MT – PersonEntity: Name: NameFull: Johnson CR – PersonEntity: Name: NameFull: Kapp DS – PersonEntity: Name: NameFull: Tewari KS – PersonEntity: Name: NameFull: Chan JK IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 02 Text: 2026 Feb 18 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2352-5789 Numbering: – Type: volume Value: 64 Titles: – TitleFull: Gynecologic oncology reports Type: main |
| ResultId | 1 |